Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Small Virus to Deliver Small Antibodies: New Targeted Therapies Based on AAV Delivery of Nanobodies
Noelia Silva-Pilipich, Cristian Smerdou, Lucía Vanrell
Microorganisms (2021) Vol. 9, Iss. 9, pp. 1956-1956
Open Access | Times Cited: 11

Showing 11 citing articles:

Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114726-114726
Open Access | Times Cited: 42
α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice
Yemima R. Butler, Yuqing Liu, Ramhari Kumbhar, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Nanoscale warriors against viral invaders: a comprehensive review of Nanobodies as potential antiviral therapeutics
Vaishali Verma, N. D. Sinha, A. Raja
mAbs (2025) Vol. 17, Iss. 1
Open Access
Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses
Noelia Silva-Pilipich, Ester Blanco, Teresa Lozano, et al.
Cancer Letters (2023) Vol. 561, pp. 216139-216139
Open Access | Times Cited: 10
Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 3
The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine
Michelle Koerselman, Lisanne Morshuis, Marcel Karperien
Acta Biomaterialia (2023) Vol. 170, pp. 1-14
Open Access | Times Cited: 7
Structural Basis of the Allosteric Inhibition of Human ABCG2 by Nanobodies
Rossitza N. Irobalieva, Ioannis Manolaridis, Scott M. Jackson, et al.
Journal of Molecular Biology (2023) Vol. 435, Iss. 19, pp. 168234-168234
Open Access | Times Cited: 7
Local Delivery of Immunomodulatory Antibodies for Gastrointestinal Tumors
Noelia Silva-Pilipich, Ángela Covo-Vergara, Cristian Smerdou
Cancers (2023) Vol. 15, Iss. 8, pp. 2352-2352
Open Access | Times Cited: 2
Anti-SOD1 Nanobodies That Stabilize Misfolded SOD1 Proteins Also Promote Neurite Outgrowth in Mutant SOD1 Human Neurons
Meenakshi Sundaram Kumar, Megan E. Fowler-Magaw, Daniel Kulick, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 24, pp. 16013-16013
Open Access | Times Cited: 3
Isolated Variable Domains of an Antibody Can Assemble on Blood Coagulation Factor VIII into a Functional Fv-like Complex
Svetlana A. Shestopal, Leonid A. Parunov, Philip Olivares, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8134-8134
Open Access | Times Cited: 2
Vesicular Glutamate Transporters in Astrocytes as Potential New Therapeutic Targets: Astrocyte-targeted Viral Vectors Expressing Inhibitory Nanobodies
Roberta De Ceglia, Andrea Volterra
CHIMIA International Journal for Chemistry (2022) Vol. 76, Iss. 12, pp. 1033-1033
Open Access
Page 1

Scroll to top